| Book
4: General biohazards - an introducton |
 |
Biosafety
is concerned with the containment methods required when managing
parasites, infectious agents and infected or potentially infected
animals, tissues or other materials, as well as radiation. Biological
fluids such as blood, and even cell lines (particularly primary
cell cultures), may harbour a variety of pathogenic organisms,
such as HIV, hepatitis viruses or prions, and thus are a biohazard
risk.
The purpose
of biosafety is to reduce exposure of persons, animals and the
outside environment to potentially hazardous agents. Unnecessary
or avoidable exposure to such hazards is ethically unacceptable.
Organisms have traditionally been classified according to their
characteristics, such as pathogenicity, infectious dose required
for disease, mode of transmission, hosts and availability of
preventive measures and treatment. Although organisms have been
classified according to risk groups in the past, it is arguably
more appropriate to consider the handling and containment requirements,
as outlined below.
Samples
obtained, whether of prokaryotic origin or from human or animal
subjects, must be obtained with the consent of the agency or
subject, and the material is subject to the ethical and other
considerations of the provider. Care must be exercised to prevent
the importation of potentially biohazardous materials into a
facility currently not involved with that material.
The Directorate:
Genetic Resources of the National Department of Agriculture,
Private Bag X973, Pretoria, 0001, must be consulted about pilot
experiments, trials or the release into the environment of genetically
modified organisms in South Africa, except where this involves
only basic research in a contained environment.
Reasonable
precautions must be taken with any work involving biological
material or radiation. The difficulty lies in defining reasonable
or absolute requirements. It is unlikely that we will be able
to ensure a situation of no risk, as there may be unknown agents
or effects still to be defined. It should be noted that the
risk to, or exposure of, laboratory workers or researchers is
often less than in the case of health care workers such as nurses
or clinicians, who have regular and frequent contact with patients
or body fluids harbouring a variety of infectious agents. In
all cases however, one attempts to minimise exposure and risk.
The recommendations
that follow apply essentially to immunocompetent individuals.
Immunocompromised individuals are at increased risk and should
be advised to avoid additional risk. Persons who believe they
may be immunocompromised should inform their supervisory authority,
and their case should be carefully considered before exposure
occurs. In any deliberation, perhaps the most important safety
consideration is 'distance'. Distance is not simply geographical
location, but implies barriers, whether these are full-body
protective clothing for avoidance of pathogenic organisms, or
lead screens to confine radiation exposure.
In a broad
context, work should not contravene other general ethical considerations,
such as those approved in the MRC Guidelines on Ethics for Medical
Research, the Declaration of Helsinki, the Cartagena Protocol
on Biosafety or the Convention on Biological Diversity.
Detailed
laboratory biosafety guidelines are beyond the scope of this
document, but are available in publications dealing with various
pathogens or from the Internet, such as the Canadian Guidelines.
|